eMJA: Misleading advertising of PI-based drug information?

* It should be noted that the question mark in the title was added at the Editor's discretion.

To the Editor: Why are those who market officially sanctioned information about pharmaceutical products not constrained by the advertising standards imposed on those who sell these products? Medicines Australia, which formulates a code of conduct for the pharmaceutical industry, imposes penalties, both financial and withdrawal of offending material, against misleading advertising of pharmaceutical products1,2 Why are similar standards not applied to advertising of information about these products?

NB: If you are registered with the eMJA, your username is the email address you have provided.
AMA members can login using their AMA username and password.

If you don't have a login, click here to register for immediate free access

Username:
Password:

Password forgotten? Click here What is my username?

Other articles have cited this article: